381 related articles for article (PubMed ID: 26195723)
21. Enhanced expression of SOS1 is detected in prostate cancer epithelial cells from African-American men.
Timofeeva OA; Zhang X; Ressom HW; Varghese RS; Kallakury BV; Wang K; Ji Y; Cheema A; Jung M; Brown ML; Rhim JS; Dritschilo A
Int J Oncol; 2009 Oct; 35(4):751-60. PubMed ID: 19724911
[TBL] [Abstract][Full Text] [Related]
22. MNX1 Is Oncogenically Upregulated in African-American Prostate Cancer.
Zhang L; Wang J; Wang Y; Zhang Y; Castro P; Shao L; Sreekumar A; Putluri N; Guha N; Deepak S; Padmanaban A; Creighton CJ; Ittmann M
Cancer Res; 2016 Nov; 76(21):6290-6298. PubMed ID: 27578002
[TBL] [Abstract][Full Text] [Related]
23. Differences in frequency of ERG oncoprotein expression between index tumors of Caucasian and African American patients with prostate cancer.
Rosen P; Pfister D; Young D; Petrovics G; Chen Y; Cullen J; Böhm D; Perner S; Dobi A; McLeod DG; Sesterhenn IA; Srivastava S
Urology; 2012 Oct; 80(4):749-53. PubMed ID: 22950997
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients.
Brooks JD; Wei W; Hawley S; Auman H; Newcomb L; Boyer H; Fazli L; Simko J; Hurtado-Coll A; Troyer DA; Carroll PR; Gleave M; Lance R; Lin DW; Nelson PS; Thompson IM; True LD; Feng Z; McKenney JK
PLoS One; 2015; 10(7):e0132343. PubMed ID: 26172920
[TBL] [Abstract][Full Text] [Related]
25. High alpha-methylacyl-CoA racemase (AMACR) is associated with ERG expression and with adverse clinical outcome in patients with localized prostate cancer.
Box A; Alshalalfa M; Hegazy SA; Donnelly B; Bismar TA
Tumour Biol; 2016 Sep; 37(9):12287-12299. PubMed ID: 27271990
[TBL] [Abstract][Full Text] [Related]
26. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
[TBL] [Abstract][Full Text] [Related]
27. Chromosome 8 markers of metastatic prostate cancer in African American men: gain of the MIR151 gene and loss of the NKX3-1 gene.
Barnabas N; Xu L; Savera A; Hou Z; Barrack ER
Prostate; 2011 Jun; 71(8):857-71. PubMed ID: 21456068
[TBL] [Abstract][Full Text] [Related]
28. Clonal evaluation of early onset prostate cancer by expression profiling of ERG, SPINK1, ETV1, and ETV4 on whole-mount radical prostatectomy tissue.
Lu Z; Williamson SR; Carskadon S; Arachchige PD; Dhamdhere G; Schultz DS; Stricker H; Peabody JO; Jeong W; Chitale DA; Bismar TA; Rogers CG; Menon M; Gupta NS; Palanisamy N
Prostate; 2020 Jan; 80(1):38-50. PubMed ID: 31584209
[TBL] [Abstract][Full Text] [Related]
29. TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of Caucasian, African-American and Japanese patients.
Magi-Galluzzi C; Tsusuki T; Elson P; Simmerman K; LaFargue C; Esgueva R; Klein E; Rubin MA; Zhou M
Prostate; 2011 Apr; 71(5):489-97. PubMed ID: 20878952
[TBL] [Abstract][Full Text] [Related]
30. Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences.
Rayford W; Beksac AT; Alger J; Alshalalfa M; Ahmed M; Khan I; Falagario UG; Liu Y; Davicioni E; Spratt DE; Schaeffer EM; Feng FY; Mahal B; Nguyen PL; Den RB; Greenberger MD; Bradley R; Watson JM; Beamer M; Stamatakis L; Carmen DJ; Awasthi S; Hwang J; Weil R; Merisaari H; Mohamed N; Deane LA; Chakravarty D; Yadav KK; Yamoah K; Nair SS; Tewari AK
Commun Biol; 2021 Jun; 4(1):670. PubMed ID: 34083737
[TBL] [Abstract][Full Text] [Related]
31. Genetic ancestry, self-reported race and ethnicity in African Americans and European Americans in the PCaP cohort.
Sucheston LE; Bensen JT; Xu Z; Singh PK; Preus L; Mohler JL; Su LJ; Fontham ET; Ruiz B; Smith GJ; Taylor JA
PLoS One; 2012; 7(3):e30950. PubMed ID: 22479307
[TBL] [Abstract][Full Text] [Related]
32. Receptor tyrosine kinase recepteur d'origine nantais as predictive marker for aggressive prostate cancer in African Americans.
Bedolla RG; Shah DP; Huang SB; Reddick RL; Ghosh R; Kumar AP
Mol Carcinog; 2019 Jun; 58(6):854-861. PubMed ID: 30859654
[TBL] [Abstract][Full Text] [Related]
33. Phase II study of cytarabine in men with docetaxel-refractory, castration-resistant prostate cancer with evaluation of TMPRSS2-ERG and SPINK1 as serum biomarkers.
Dhani NC; Emmenegger U; Adams L; Jongstra J; Tannock IF; Sridhar SS; Knox JJ; Day JR; Groskopf J; Joshua AM
BJU Int; 2012 Sep; 110(6):840-5. PubMed ID: 22313860
[TBL] [Abstract][Full Text] [Related]
34. TMPRSS2-ERG fusion impacts anterior tumor location in men with prostate cancer.
Yamoah K; Lal P; Awasthi S; Naghavi AO; Rounbehler RJ; Gerke T; Berglund AE; Pow-Sang JM; Schaeffer EM; Dhillon J; Park JY; Rebbeck TR
Prostate; 2021 Feb; 81(2):109-117. PubMed ID: 33141952
[TBL] [Abstract][Full Text] [Related]
35. Prostate biopsies from black men express higher levels of aggressive disease biomarkers than prostate biopsies from white men.
Kim HS; Moreira DM; Jayachandran J; Gerber L; Bañez LL; Vollmer RT; Lark AL; Donovan MJ; Powell D; Khan FM; Freedland SJ
Prostate Cancer Prostatic Dis; 2011 Sep; 14(3):262-5. PubMed ID: 21519348
[TBL] [Abstract][Full Text] [Related]
36. Commercial Gene Expression Tests for Prostate Cancer Prognosis Provide Paradoxical Estimates of Race-Specific Risk.
Creed JH; Berglund AE; Rounbehler RJ; Awasthi S; Cleveland JL; Park JY; Yamoah K; Gerke TA
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):246-253. PubMed ID: 31757784
[TBL] [Abstract][Full Text] [Related]
37. Validation of a genomic classifier for prediction of metastasis and prostate cancer-specific mortality in African-American men following radical prostatectomy in an equal access healthcare setting.
Howard LE; Zhang J; Fishbane N; Hoedt AM; Klaassen Z; Spratt DE; Vidal AC; Lin D; Hitchins MP; You S; Freeman MR; Yamoah K; Davicioni E; Freedland SJ
Prostate Cancer Prostatic Dis; 2020 Sep; 23(3):419-428. PubMed ID: 31844180
[TBL] [Abstract][Full Text] [Related]
38. Predicting Prostate Cancer Progression as a Function of ETS-related Gene Status, Race, and Obesity in a Longitudinal Patient Cohort.
Cullen J; Young D; Chen Y; Degon M; Farrell J; Sedarsky J; Baptiste W; Rosen P; Tolstikov V; Kiebish M; Kagan J; Srivastava S; Kuo HC; Moncur JT; Rosner IL; Narain N; Akmaev V; Petrovics G; Dobi A; McLeod DG; Srivastava S; Sesterhenn IA
Eur Urol Focus; 2018 Dec; 4(6):818-824. PubMed ID: 28753864
[TBL] [Abstract][Full Text] [Related]
39. Racial disparity of epidermal growth factor receptor expression in prostate cancer.
Shuch B; Mikhail M; Satagopan J; Lee P; Yee H; Chang C; Cordon-Cardo C; Taneja SS; Osman I
J Clin Oncol; 2004 Dec; 22(23):4725-9. PubMed ID: 15570072
[TBL] [Abstract][Full Text] [Related]
40. Molecular characterization of prostate cancer in Middle Eastern population highlights differences with Western populations with prognostic implication.
Abdelsalam RA; Khalifeh I; Box A; Kalantarian M; Ghosh S; Abou-Ouf H; Lotfi T; Shahait M; Palanisamy N; Bismar TA
J Cancer Res Clin Oncol; 2020 Jul; 146(7):1701-1709. PubMed ID: 32350606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]